List of Excipients in API guanfacine er
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing guanfacine er
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 | ANHYDROUS LACTOSE |
| Direct_Rx | guanfacine er | 72189-469 | FUMARIC ACID |
| Direct_Rx | guanfacine er | 72189-469 | HYPROMELLOSE 2208 |
| Direct_Rx | guanfacine er | 72189-469 | MAGNESIUM STEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for guanfacine er
Excipient focus: ANHYDROUS LACTOSE
guanfacine er drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
guanfacine er drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| >Company | >Ingredient | >NDC |
Excipient focus: FUMARIC ACID
guanfacine er drug variants containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL DIBEHENATE
guanfacine er drug variants containing GLYCERYL DIBEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing GLYCERYL DIBEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
guanfacine er drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
guanfacine er drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
guanfacine er drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
guanfacine er drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
guanfacine er drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
guanfacine er drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
guanfacine er drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | guanfacine er | 72189-597 |
| >Company | >Ingredient | >NDC |
guanfacine er drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | guanfacine er | 72189-469 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch